GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » 3-Year Revenue Growth Rate

China National Medicines (SHSE:600511) 3-Year Revenue Growth Rate : 7.20% (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines 3-Year Revenue Growth Rate?

China National Medicines's Revenue per Share for the three months ended in Mar. 2024 was ¥16.07.

During the past 12 months, China National Medicines's average Revenue per Share Growth Rate was 10.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of China National Medicines was 37.20% per year. The lowest was 1.00% per year. And the median was 18.30% per year.


Competitive Comparison of China National Medicines's 3-Year Revenue Growth Rate

For the Medical Distribution subindustry, China National Medicines's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Medicines's 3-Year Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where China National Medicines's 3-Year Revenue Growth Rate falls into.



China National Medicines 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


China National Medicines  (SHSE:600511) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


China National Medicines 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of China National Medicines's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Medicines (SHSE:600511) Business Description

Traded in Other Exchanges
N/A
Address
No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines